Sio Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Sio Capital Management's ALLO Position: Q3 2026 in Review
Sio Capital Management reduced its Allogene Therapeutics (ALLO) stake by 32% in Q3 2026, selling an estimated $8.03M and leaving 9,104,151 shares worth $14.6M. The position accounts for 2.76% of the portfolio, ranked #12.
Sio Capital Management first reported a position in ALLO in Q2 2026 and has held it in 2 quarters since. The position peaked at $27.7M in Q2 2026. 198 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Sio Capital Management held 9,104,151 shares of Allogene Therapeutics worth $14.6M as of Q3 2026.
- Sio Capital Management sold 4,219,280 Allogene Therapeutics shares in Q3 2026, an estimated $8.03M.
- Allogene Therapeutics made up 2.76% of Sio Capital Management's portfolio in Q3 2026, its #12 holding.
- Sio Capital Management first reported a position in Allogene Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Sio Capital Management's Allogene Therapeutics position peaked at $27.7M in Q2 2026.
- 198 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Sio Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.